Dry Eye Syndrome



A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome


Condition:   Dry Eye Syndromes
Interventions:   Drug: ADX-102 Ophthalmic Solution (0.5%);   Drug: ADX-102 Ophthalmic Solution (0.1%);   Drug: ADX-102 Ophthalmic Lipid Solution (0.5%)
Sponsor:   Aldeyra Therapeutics, Inc.
Recruiting - verified May 2017


Walnut Shell Glasses Moxibustion for Dry Eye Syndrome


Condition:   Dry Eye
Interventions:   Procedure: Walnut Shell Glasses Moxibustion;   Drug: Sodium hyaluronate eye drops
Sponsor:   Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Recruiting - verified April 2017


Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome


Condition:   Dry Eye Syndrome
Interventions:   Drug: AVX012 Low dose Ophthalmic Solution;   Drug: AVX012 High dose Ophthalmic Solution;   Drug: Placebo (vehicle)
Sponsor:   Avizorex Pharma, S.L.
Recruiting - verified May 2017


Effect of Single Instillation of Three Different Topical Lubricants on Tear Film Thickness in Patients With Dry Eye Syndrome


Condition:   Dry Eye Syndromes
Interventions:   Device: Neovis Total Multi® Eye Drops;   Device: Vismed Multi® Eye Drops;   Device: Hydrabak® Eye Drops
Sponsor:   Medical University of Vienna
Recruiting - verified May 2017


Safety and Efficacy of TOP1630 for Dry Eye Syndrome


Condition:   Dry Eye Syndrome
Interventions:   Drug: TOP1630 Ophthalmic Solution;   Drug: Placebo to TOP1630 Ophthalmic Solution
Sponsor:   Topivert Pharma Ltd
Recruiting - verified May 2017


Cross-linked Hyaluronic Acid and Coenzyme Q10 in the Treatment of Dry Eye


Condition:   Dry Eye Syndrome
Interventions:   Device: XLHA+CoQ10;   Device: Hyaluronic acid (HA)
Sponsor:   Azienda Ospedaliera Universitaria Policlinico "G. Martino"
Completed - verified March 2017


Safety and Efficacy of BRM421 for Dry Eye Syndrome


Condition:   Dry Eye Syndrome
Intervention:   Drug: BRM421
Sponsor:   BRIM Biotechnology Inc.
Not yet recruiting - verified February 2017


Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2


Condition:   Dry Eye Syndrome
Interventions:   Drug: RGN-259;   Drug: Placebo
Sponsor:   ReGenTree, LLC
Recruiting - verified November 2016


Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye


Condition:   Dry Eye Syndromes
Interventions:   Drug: AGN-195263;   Drug: Vehicle
Sponsor:   Allergan
Recruiting - verified December 2016


Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction


Condition:   Dry Eye Syndrome
Interventions:   Device: intense pulsed light;   Drug: Tobramycin and Dexamethasone Ophthalmic Ointment
Sponsor:   Peking University Third Hospital
Not yet recruiting - verified November 2016


Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome


Condition:   Dry Eye Syndrome
Interventions:   Drug: HU00701;   Drug: HU007;   Drug: Restasis;   Drug: Placebo
Sponsor:   Huons Co.,Ltd.
Recruiting - verified September 2016


A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye


Condition:   Dry Eye Syndromes
Interventions:   Drug: Omega 3;   Drug: Optive Advanced;   Drug: Optive
Sponsors:   The University of New South Wales;   Allergan
Not yet recruiting - verified August 2016


Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye


Condition:   Dry Eye Syndromes
Interventions:   Drug: AGN-195263;   Drug: Vehicle
Sponsor:   Allergan
Recruiting - verified October 2016


Effect of Nursing Care on Prevention of Dry Eye


Condition:   Dry Eye Syndromes
Interventions:   Device: LACRIBELL®;   Device: VIDISIC® GEL
Sponsors:   Diego Dias de Araújo;   State University of Montes Claros;   Conselho Nacional de Desenvolvimento Científico e Tecnológico
Recruiting - verified February 2017


Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye Syndrome


Condition:   Dry Eye Syndrome
Intervention:  
Sponsor:   National Taiwan University Hospital
Enrolling by invitation - verified December 2016


Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome


Condition:   Dry Eye Syndrome
Interventions:   Device: T2762;   Device: Optive
Sponsor:   Laboratoires Thea
Terminated - verified March 2017


Feasibility of IPL for Reducing Dry Eye Symptoms Caused by MGD


Condition:   Dry Eye Syndromes
Intervention:   Device: M22-IPL
Sponsor:   Lumenis Ltd.
Completed - verified February 2017


Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1


Condition:   Dry Eye Syndrome
Interventions:   Drug: RGN-259;   Drug: Placebo
Sponsor:   ReGenTree, LLC
Completed - verified November 2016


Effect of Benzalkonium Chloride Containing Eye Drops on the Conjunctival Bacterial Flora of Dry Eye Patients


Condition:   Dry Eye Syndromes
Interventions:   Drug: Prosicca;   Drug: Prosicca sine;   Other: Bacterial culture
Sponsor:   Medical University of Vienna
Not yet recruiting - verified May 2017


Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye


Condition:   Dry Eye Syndrome
Intervention:   Drug: SYSTANE® ULTRA Lubricant Eye Drops
Sponsor:   Alcon Research
Completed - verified July 2016


Added Benefits of Lachrymal Substitute Gel During the Night in Patients With Moderate to Severe Dry Eye Syndrome


Condition:   Dry Eye Syndromes
Interventions:   Device: Thealoz Duo Gel and Thealoz Duo eye drops;   Device: Thealoz Duo eye drops
Sponsor:   Medical University of Vienna
Completed - verified March 2017


Study of ACCS Eye Drops in Treating Dry Eye


Condition:   Dry Eye Syndrome
Interventions:   Drug: ACCS;   Drug: Refresh Lubricant Eye Drops
Sponsors:   Noveome Biotherapeutics, formerly Stemnion;   U.S. Navy Bureau of Medicine
Completed - verified November 2016


Impairment of Reading Ability in Dry Eye Patients


Condition:   Dry Eye Syndromes
Interventions:   Other: 30 minutes sustained reading;   Other: Dry eye exam
Sponsors:   Johns Hopkins University;   Allergan
Completed - verified March 2017


In Vivo Measurement of Corneal Epithelial Changes in Dry Eye Patients


Condition:   Dry Eye Syndrome
Intervention:   Other: SYSTANE® Gel Drop lubricant eye gel
Sponsor:   Alcon Research
Completed - verified February 2012


Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease


Condition:   Dry Eye Syndromes
Interventions:   Drug: Euphrasia-based homeopathic therapy;   Drug: Cyclosporin solution
Sponsor:   University of Missouri-Columbia
Terminated - verified November 2016

Refine Your Search Advanced Search